Clinical trial

A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

NCT03127631

Study summary

ClinicalTrials.gov

A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

BEHAVIORAL · Unmapped registry intervention Nutrition Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Exercise Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Smoking cessation Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention ACE inhibitor Find medicine records · Find other trials using this name

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2015-10-21

PhaseNA

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Cardiovascular Diseaseverified · MONDO: cardiovascular disorder

Interventions

NutritionBEHAVIORAL

ExerciseBEHAVIORAL

Smoking cessationBEHAVIORAL

Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin)DRUG

ACE inhibitorDRUG

Sponsors & collaborators

McMaster Universitylead sponsor

Prostate Cancer Canadacollaborator

Canadian Cancer Society (CCS)collaborator

Tolmar Inc.collaborator

Mapped research locations

São PauloSão Paulo, Brazil7 MontrealQuebec, Canada4 Porto AlegreRio Grande do Sul, Brazil3 TorontoOntario, Canada2 LondonOntario, Canada2 HamiltonOntario, Canada2 AdelaideSouth Australia, Australia2 PhiladelphiaPennsylvania, United States1 DallasTexas, United States1 VancouverBritish Columbia, Canada1 IstanbulTurkey (Türkiye)1 OttawaOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03127631 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.